Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
12.30
+0.05 (0.41%)
Dec 2, 2025, 4:00 PM EST - Market closed
Embecta Market Cap
Embecta has a market cap or net worth of $719.71 million as of December 3, 2025. Its market cap has decreased by -17.12% in one year.
Market Cap
719.71M
Enterprise Value
1.94B
1-Year Change
-17.12%
Ranking
Category
Stock Price
$12.30
Market Cap Chart
Since March 22, 2022, Embecta's market cap has decreased from $2.68B to $719.71M, a decrease of -73.11%. That is a compound annual growth rate of -29.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 719.71M | -40.05% |
| Dec 31, 2024 | 1.20B | 10.14% |
| Dec 29, 2023 | 1.09B | -24.67% |
| Dec 30, 2022 | 1.45B | -45.94% |
| Mar 22, 2022 | 2.68B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |